Interaction of Huntington disease protein with transcriptional activator Sp1

Molecular and Cellular Biology

Volumn 22, Issue 5, 2002, Pages 1277-1287

  Li, Shi Hua ^a   Cheng, Anna L ^a   Zhou, Hui ^a   Lam, Suzanne ^a   Rao, Manjula ^a   Li, He ^a   Li, Xiao Jiang ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUNTINGTIN; POLYGLUTAMINE; TRANSCRIPTION FACTOR SP1;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; IMMUNOPRECIPITATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION;

ANIMALS; CELL COMPARTMENTATION; HUMANS; HUNTINGTON DISEASE; MICE; MICE, TRANSGENIC; MUTATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PEPTIDES; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECEPTORS, NERVE GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRINUCLEOTIDE REPEAT EXPANSION;

MUS MUSCULUS;

EID: 0036173896     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.5.1277-1287.2002     Document Type: Article

References (43)

1. Nerve growth factor up-regulates the N-methyl-D-aspartate receptor subunit 1 promoter in PC12 cells
2. Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin
3. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene
4. Three zinc finger nuclear proteins, Sp1, Sp3, and a ZBP-89 homologue, bind to the cyclic adenosine monophosphate-responsive sequence of the bovine adrenodoxin gene and regulate transcription
5. Sp1 and its likes: Biochemical and functional predictions for a growing family of zinc finger transcription factors
6. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif
7. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
8. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
9. Transcriptional activation modulated by homopolymeric glutamine and proline stretches
10. Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology
11. The influence of huntingtin protein size on nuclear localization and cellular toxicity
12. Sp1-mediated transcriptional activation is repressed by Sp3
13. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration
14. Amyloid formation by mutant huntingtin: Threshold, progressivity and recruitment of normal polyglutamine proteins
15. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
16. Pitfall of an internal control plasmid: Response of Renilla luciferase (pRL-TK) plasmid to dihydrotestosterone and dexamethasone
17. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain
18. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells
19. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice
20. Huntington aggregates may not predict neuronal death in Huntington's disease
21. Aminoterminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity
22. Cellular defects and altered gene expression in PC12 cells stably expressing mutant huntingtin
23. Interaction of huntingtin-associated protein with dynactin P150Glued
24. Neurological abnormalities in a knock-in mouse model of Huntington's disease
25. Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1
26. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
27. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates
28. Regulatory elements and transcriptional regulation by testosterone and retinoic acid of the rat nerve growth factor receptor promoter
29. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity
30. Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation
31. Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases
32. Nuclear targeting of mutant huntingtin increases toxicity
33. Regulation of the rat p75 neurotrophin receptor promoter by GC element binding proteins
34. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated fulllength HD cDNA
35. Molecular cloning and characterization of the 5′ region of the mouse trkA proto-oncogene
36. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
37. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin
38. Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription
39. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription
40. Characterization of the complete genomic structure of human thromboxane synthase gene and functional analysis of its promoter
41. Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice
42. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease
43. Glutamine repeats and neurodegeneration